Albireo Pharma (ALBO) Reports FY16 Loss of $13.16

Albireo Pharma (NASDAQ: ALBO) reported FY16 EPS of ($13.16), versus ($25.49) reported last year. Revenue for the year came in at $11.4 million, versus $5.1 million reported last year.

For earnings history and earnings-related data on Albireo Pharma (ALBO) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
• Wolfspeed (WOLF) Misses Q4 EPS by 174c; Offers Guidance